Evidence map›Paper›PMID 42656695›Full record

ArticleFrontiers in aging neuroscience2026

Semantic control across Alzheimer's disease phenotypes: cognitive mechanisms and neural correlates.

Pilar Armas, Alejandra O Morcillo-Nieto, Sara E Zsadanyi, Sonia Karin Marques-Kiderle, Júlia Filella-Mercè, Francesco Ciongoli, Isabel Sala, M Belen Sanchez-Saudinos, Sara Rubio-Guerra, Nuole Zhu and 14 more

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Pilar ArmasSant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Alejandra O Morcillo-NietoSant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Sara E ZsadanyiSant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Sonia Karin Marques-KiderleSant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Júlia Filella-MercèSant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Francesco CiongoliFaculty of Health Sciences, Universitat Oberta de Catalunya, Barcelona, Spain.
Isabel SalaSant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
M Belen Sanchez-SaudinosSant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Sara Rubio-GuerraSant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Nuole ZhuSant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Isabel BarroetaSant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Maria Carmona-IraguiSant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Ignacio Illán-GalaSant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Daniel AlcoleaSant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Alberto LleoSant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Juan ForteaSant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Stephanie M GrassoDepartment of Speech, Language, and Hearing Sciences, The University of Texas at Austin, Austin, TX, United States.
Marco CalabriaFaculty of Health Sciences, Universitat Oberta de Catalunya, Barcelona, Spain.
Javier HernandoUniversitat Politècnica de Catalunya (UPC), Barcelona, Spain.
Elizabeth JefferiesDepartment of Psychology, University of York, York, United Kingdom.
Matthew A Lambon RalphMedical Research Council (MRC) Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, United Kingdom.
Richard J BinneyDepartment of Psychology, Bangor University, Gwynedd, United Kingdom.
Alexandre BejaninSant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Miguel A Santos-SantosSant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Funding

DS-ARC: A Remote Digital Cognitive Assessment for Down Syndrome-Associated Alzheimer's DiseaseR01AG081394 · NIA · WASHINGTON UNIVERSITY · PI Jason J Hassenstab · 2023 to 2026
$6.0M
The Role of Inflammation and NGF Dysfunction in the Evolution of Alzheimer Disease Pathology in Down Syndrome-RevisionRF1AG056850 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI BUSCIGLIO, JORGE A, CUELLO, A CLAUDIO · 2018 to 2020
$5.9M
Clinical trials to prevent Alzheimer's Disease in Down SyndromeR61AG066543 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI RAFII, MICHAEL S · 2019 to 2020
$5.6M
Tau pathology in Down syndrome and Alzheimer'sRF1AG061566 · NIA · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI GRANHOLM-BENTLEY, ANN-CHARLOTTE ESTHER, MARGITTAI, MARTIN · 2019 to 2019
$3.4M
Bilingual Factors Associated with Cognitive Reserve and Linguistic Resilience in Hispanics with Primary Progressive AphasiaR01AG080470 · NIA · UNIVERSITY OF TEXAS AT AUSTIN · PI Stephanie M Grasso · 2023 to 2026
$2.8M
Biological Correlates of Alzheimer in Down Syndrome.R21AG056974 · NIA · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI GRANHOLM-BENTLEY, ANN-CHARLOTTE ESTHER · 2017 to 2018
$414k
NIA NIH HHS R01 AG080470NIA NIH HHS R01 AG081394NIA NIH HHS R21 AG056974NIA NIH HHS R61 AG066543NIA NIH HHS RF1 AG056850NIA NIH HHS RF1 AG061566
6 · The paper itself

Abstract

Introduction: Semantic cognition, our ability to understand meaning, relies on two distinct but interacting systems: one involved in knowledge representation and another in control processes. This control system is thought to comprise at least two mechanisms: controlled retrieval, which facilitates access to information relevant to a specific goal or context, and selection, which is engaged to resolve competition among multiple simultaneously active semantic representations. The present study aimed at understanding if, and how, controlled semantic cognition is impaired in Alzheimer's disease (AD), and the neuroanatomical correlates of these deficits. We supposed that in AD, semantic deficits could reflect damage to the retrieval and/or the selection mechanism and could differ according to the clinical phenotype of AD. Methods: Our sample included the typical amnestic (ADtyp, Results: Increased semantic control demands worsened performance in all groups including controls. Both patient groups were impaired in controlled retrieval, but not selection, compared to controls. Furthermore, lvPPA scored consistently lower than controls and ADtyp in all conditions of the experimental task, even the condition with the lowest semantic control demands, pointing to broader semantic difficulties beyond controlled-retrieval and selection… Exploratory analyses suggested the two mechanisms were linked to partially distinct predominant cognitive associations, controlled-retrieval with tests of semantic-knowledge and selection with executive function. Neuroimaging showed partially overlapping but distinct correlates for the two mechanisms, potentially reflecting differing reliance on semantic versus domain-general control brain networks. Conclusion: Our results refine current models of semantic dysfunction in AD, highlighting involvement of both domain-general and more specialized control mechanisms, with potential implications for differential diagnosis, symptom management, and rehabilitation planning.

Indexed as

Alzheimer’s diseasecontrolled retrievallogopenic variant primary progressive aphasianeuroimagingselection mechanismsemantic cognitionsemantic control

Identifiers

PMID42656695
PMCPMC13506867

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.